107 results
Page 3 of 6
6-K
EX-99.1
lyjyp ti3c
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
EX-99.1
ni8i4iu
27 Jul 15
Teva to Acquire Allergan Generics for $40.5 Billion
12:00am
425
fuky1zo
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
5wufqy2 cm
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
1mm2707sj4cmqv9v7
21 Apr 15
Business combination disclosure
12:00am
6-K
mdo fqb89syk2
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
e6u nrp12pr3b
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
EX-99.1
712if
6 Oct 14
Teva Announces Results of Strategic Review of Core Specialty Therapeutic Areas
12:00am
6-K
EX-99.1
zh6bc
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
she3lg
3 Jul 14
Current report (foreign)
12:00am
6-K
037 422jfnx3auqh
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
1o2augasuu5vsf
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
ik8 o2gusf
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
c649ro
13 Mar 14
Live Filing
12:00am
6-K
EX-99.1
7ii7vr3xl1gkay0ap
13 Mar 14
Live Filing
12:00am
6-K
EX-99.1
kljb3
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
xq9ckul2
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
n593y2qk 5rym
4 Dec 13
Live Filing
12:00am